Abstract 486: A phase Ib/II, open-label study evaluating the efficacy and safety of Toripalimab injection (JS001) or combination with Lenvatinib as a neoadjuvant therapy for patients with resectable hepatocellular carcinoma (HCC)
Keyword(s):
2015 ◽
Vol 62
◽
pp. S856-S857
◽
2021 ◽
Vol 77
(18)
◽
pp. 441
Keyword(s):
2015 ◽
Vol 149
(4)
◽
pp. 971-980.e1
◽
Keyword(s):
2018 ◽
Vol 45
(5)
◽
pp. 529-539
◽